Drug Abuse

SCHEDULES

List of drugs included in Schedule I

ACETYLMETHADOL (3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

ALLYLPRODINE (3-allyl-l-methyl-4-phenyl-4-propionoxypiperidine)

ALPHACETYLMETHADOL (alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

ALPHAMEPRODINE (alpha-3-ethyl-l-methyl-4-phenyl-4-propionoxypiperidine)

ALPHAMETHADOL (alpha-6-dimethylamino-4,4-diphenyl-3-heptanol)

ALPHAPRODINE (alpha- 1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

ANILERIDINE (1 para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

BENZETHIDINE (1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

BENZYLMORPHINE (3-benzylmorphine)

BETACETYLMETHADOL (beta-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

BETAMEPRODINE (beta-3-ethyl-l-methyl-4-phenyl-4-propionoxypiperidine)

BETAMETHADOL (beta-6-dimethylamino-4,4-diphenyl-3-heptanol)

BETAPRODINE (beta- 1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

CANNABIS and CANNABIS RESIN and EXTRACTS and TINCTURES Of CANNABIS

CLONITAZENE (2para-chlorbenzyl-l-diethylaminoethyl-5-nitrobenzimidazole)

COCA LEAF

COCAINE (methyl ester of benzoylecgonine)

CONCENTRATE OF POPPY STRAW (the material arising when poppy straw has entered into a process for the concentration of its alkaloids, when such material is made available in trade)

DESOMORPHINE (dihydrodeoxymorphine)

DEXTROMORAMIDE ((+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(I -pyrrolidinyl) butyl] morpholine

DIAMPROMIDE (N-[2-methylphenethylamino) propyl] propionanilide)

DIETHYLTHIAMBUTENE (3-diethylamino-l,l-di-(2'-thienyl)-1-butene)

DIHYDROMORPHINE

DIMENOXADOL (2-dimethylaminoethyl-l-ethoxy-l,l-diphenylacetate)

DIMEPHEPTANOL (6-dimethylamino-4,4-diphenyl-3-heptanol)

DIMETHYLTHIAMBUTENE (3-dimethylamino-1,1-di-(2'-thienyl)-1-butene)

DIOXAPHETYL BUTYRATE (ethyl 4-morpholino-2,2-diphenylbutyrate)

DIPHENOXYLATE (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

DIPIPANONE (4,4-diphenyl-6-piperidine-3-heptanone)

ECCONINE, its esters and derivatives which are convertible to ecgonine and cocaine

ETHYLMETHYLTHIAMBUTENE (3-ethylmethylamino-l,l-di-(2'-thienyl)-1-butene)

ETONITAZENE (1-diethylaminoethyl-2para-ethoxybenzyl-5-nitrobenzimidazole)

ETOXERIDINE (1-[2-(2-hydroxyethoxy) ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester)

FURETHIDINE (1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

HEROIN (diacetylmorphine)

HYDROCODONE (dihydrocodeinone)

HYDROMORPHINOL (14-hydroxydihydromorphine)

HYDROMORPHONE (dihydromorphinone)

HYDROYYPETHIDINE (4-meta-hydroxyphenyl-l-methylpiperidine-4-carboxylic acid ethyl ester)

ISOMETHADONE (6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)

KETOBEMIDONE (4-meta-hydroxyphenyl-l-methyl-4-propionylpiperidine)

LEVOMETHORPHAN* ((-)-3-methoxy-N-methylmorphinan)

LEVOMORAMIDE ((-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

LEVOPHENACYLMORPHAN ((-)-3-hydroxy-N-phenacylmorphinan)

LEVORPHANOL * ((-)-3-hydroxy-N-methylmorphinan)

METAZOCINE (2'-hydroxy-2,5,9-trimethyl-6,7-benzomorphan)

METHADONE (6-dimethylamino-4,4-diphenyl-3-heptanone)

METHYLDESORPHINE (6-methyl-delta 6-deoxymorphine)

METHYLDIHYDROMORPHINE (6-methyldihydromorphine) 1-Methyl-4-phenylpiperidine-4-carboxylic acid

METOPON (5-methyidihydromorphinone)

MORPHERIDINE (1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

MORPHINE

MORPHINE METHOBROMIDE and other pentavalent nitrogen morphine derivatives

MORPHINE-N-OxIDE

MYROPHINE (myristylbenzylmorphine)

NICOMORPFIINE 3,6-dinicotinylmorphine)

NORLEVORPHANOL ((-)-3-hydroxymorphinan)

NORMETHADONE (6-dimethylamino-4,4-diphenyl-3-hexanone)

NORMORPHINE (demethylmorphine)

OPIUM

OXYCODONE (14-hydroxydihydrocodeinone)

OXYMORPHONE (14-hydroxydihydromorphinone)

PETHIDINE (1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

PHENADOXONE (6-morpholino-4,4-diphenyl-3-heptanone)

PHENAMPROMIDE (N-(1-methyl-2-piperidinoethyl) propionanilide)

PHENAZOCINE (2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan)

PHENOMORPHAN (3-hydrox-N-phenethylmorphinan)

PHENOPERIDINE (1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

PIMINODINE (4-phenyl-l-(3-phenylaminopropyl) piperidine-4-carboxylic acid ethyl ester)

PROHEPTAZINE (1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane)

PROPERIDINE (1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester)

RACEMETHORPHAN ((f)-3-methoxy-N-methylmorphinan)

RACEMORAMIDE ((f)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrroldinyl) butyl] morpholine)

RACEMORPHAN ((±)-3-hydroxy-N-methylmorphinan)

THEBACON (acetyldihydrocodeinone)

THEBAINE

TRIMEPERIDINE (1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine); and

The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
The esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule whenever the existence of such esters or ethers is possible;
The salts of the drugs listed in this Schedule, including the salts of esters, ethers and isomers as provided above whenever the existence of such salts is possible.

* Dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-Hydroxy-N-methylmorphinan) are specifically excluded from this Schedule.

Commentary

1. See comments on article 2, paragraph 1 and on article 3, paragraph 3, subparagraph (iii).

2. The entry "Concentrate of poppy straw" in the above list reproduces the text established by the Proces-Verbal of Rectification, dated 18 January 1961 1 and given in Schedule I of the Single Convention reproduced in United Nations, Treaty Series, vol. 520, p. 151. This rectification was made in all five language versions.

3. The following drugs have at the date of this writing been added to Schedule I:

ACETORPHINE 2

BEZITRAMIDE 3

CODOXIME 4

ETORPHINE2

FENTANYL5

METHADONE-INTERMEDIATE 5

MORAMIDEANTERMEDIATE 5

NORACYMETHADOL 5

NORPIPANONE 5

PETHIDINE-INTERMEDIATE A 5

PETHIDINE-INTERMEDIATE B 5

PETHIDINE-INTERMEDIATE C 5

PIRITRAMIDE 6

4. Further reports of the Commission on Narcotic Drugs, beginning with the report of the twenty-fifth session, may be consulted; see also future editions of Multilingual List of Narcotic Drugs under International Control, New York, 1968 (E/CN.7/513, United Nations publication, Sales No. 69.XI.1); and see communications of the Secretary-General pursuant to article 3, paragraph 7.

1 See Circular Note of the Secretary-General C.N.131.1961. Treaties-1, dated 17 October 1961.

2 Commission on Narcotic Drugs, report on the twenty-first session (1966), paragraph 61; Official Records of the Economic and Social Council, Forty-second Session, Supplement No. 2.

3 Commission on Narcotic Drugs, report on the twenty-third session (1969), paras. 35-36; Official Records of the Economic and Social Council, Forty-sixth Session, document E/4606/Rev. l.

4 Commission on Narcotic Drugs, report on the twenty-second session (1968), paras. 38-40, Official Records of the Economic and Social Council, Forty-fourth Session, Supplement No. 2.

5 Commission on Narcotic Drugs, report on the nineteenth session (1964), para. 157; Official Records of the Economic and Social Council, Thirty-seventh Session, Supplement No. 9.

6 Commission on Narcotic Drugs, report on the twentieth session (1965), para. 54; Official Records of the Economic and Social Council, Fortieth Session, Supplement No. 2.

List of drugs included in Schedule II

ACETYLDIHYDROCODEINE

CODEINE (3-methylmorphine)

DEXTROPROPOXYPHENE ((+)-4-dimethylamino-3-methyl-1,2-diphenyl-2-propionoxybutane)

DIHYDROCODEINE

ETHYLMORPHINE (3-ethylmorphine)

NORCODEINE (N-demethylcodeine)

PHOLCODINE (morpholinylethylmorphine); and

The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
The salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible.

Commentary

1. See comments on article 2, paragraph 2 and on article 3, paragraph 3, subparagraph (iii).

2. The following drugs have at the date of this writing been added to Schedule 11:

NICODINE 1

PROPIRAM 2

3. The following drug was deleted from Schedule II:

DEXTROPROPOXYPHENEI

4. See also the documents referred to at the end of the comments on Schedule I.
 

1 See foot-note 5 to Schedule 1.

2 Document E/CN.7/537, paras. 44-46; Commission on Narcotic Drugs, report on the twenty-fourth session, paras. 56-57; Official Records of the Economic and Social Council, Fifty-second Session, Supplement No. 2.

List of preparations included in Schedule III

1. Preparations of:

Acetyldihydrocodeine,

Codeine,

Dextropropoxyphene,

Dihydrocodeine,

Ethylmorphine,

Norcodeine, and

Pholcodine

when

(a) Compounded with one or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health; and

(b) Containing not more than 100 milligrammes of the drug per dosage unit and with a concentration of not more than 2.5 per cent in undivided preparations.

2. Preparations of cocaine containing not more than 0.1 per cent of cocaine calculated as cocaine base and preparations of opium or morphine containing not more than 0.2 per cent of morphine calculated as anhydrous morphine base and compounded with one or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.

3. Solid dose preparations of diphenoxylate containing not more than 2.5 milligrammes of diphenoxylate calculated as base and not less than 25 microgrammes of atropine sulphate per dosage unit.

4. Pulvis ipecacuanhae et opii compositus

10 per cent opium in powder
10 per cent ipecacuanha root, in powder well mixed with
80 per cent of any other powdered ingredient containing no drug.

5. Preparations conforming to any of the formulae listed in this Schedule and mixtures of such preparations with any material which contains no drug.

Commentary

1. See comments on article 2, paragraph 4 and on article 3, paragraph 4.

2. The following rectification of the Spanish text of Schedule III was made:

Paragraph 2 of Schedule III should read as follows:

"Los preparados de cocaina que no contengan mks de 0,1 %. de cocaina calculado como base de cocaina y los preparados de opio o de morfina con tin contenido de morfina no superior a 0,2 Y. calculado como base anhidra y esten mezc1ados con uno o varios ingredientes mds de tal modo que el preparado ofrezca muy poco o ningun peligro de abuso y de tal manera que el estupefaciente no pueda separarse par medios sencillos o en cantidades que ofrezcan peligro para la salud ptiblica".

3. The following amendments were made by the Commission on Narcotic Drugs to Schedule III in accordance with the procedure of article 3:
1. The word "dextropropoxyhene" in the list of drugs in section 1 is deleted. 2
2. Section 1, subparagraphs (a) and (b) are deleted and replaced by the following text after the word "when" "compounded with one or more ingredients and containing not more than 100 milligrammes of the drug per dosage unit and with a concentration of not more than 2.5 per cent in undivided preparation". 3
3. The words "in such a way that the preparation has no, or a negligible, risk of abuse, and" in section 2 are deleted. 3
4. The words "solid dose" at the beginning of section 3 are deleted. 3

4. See also the documents referred to at the end of the comments on Schedule 1.

1 Proces-Verbal of Rectification, signed at Headquarters of the United Nations, New York on 10 February 1967, United Nations, Treaty Series, vol. 590, pp. 325-326.

2 Report of the Commission on Narcotic Drugs referred to in foot-note 5 to the comments on Schedule I, paragraph 157.

3 Report of the Commission on Narcotic Drugs referred to in foot-note 2 to the comments on Schedule 1, paragraph 68.

List of drugs included in Schedule IV

CANNABIS and CANNABIS RESIN

DESOMORPHINE (dihydrodeoxymorphine)

HEROIN (diacetylmorphine)

KETOBEMIDONE (4-meta-hydroxyphenyl-l-methyl-4-propionylpiperidine); and

The salts of the drugs listed in this Schedule whenever the formation of such salts is possible.

Commentary

1. See comments on article 2, paragraph 5 and article 3, paragraph 5.

2. The following drugs have at the date of this writing been added to Schedule IV

ACETORPHINE 1

ETORPHINE 1

3. See also the documents refP:red to at the end of the comments on Schedule I.

1 Report of the Commission on Narcotic Drugs referred to in foot-note 4 to Schedule 1, para. 43. It was the understanding of the Commission that placing these drugs in Schedule IV would not affect their distribution for veterinary purposes.

< Prev		Next >